Almonty Industries (ASX:AII), a global producer of tungsten critical to US defence and technology sectors, has appointed Brian Fox, CPA, as its new CFO, effective Aug. 25. Fox will succeed outgoing ...

Synlait Milk (ASX:SM1) has released a preliminary update on its performance for the financial year ending July 31. The company expects underlying EBITDA to reach between $100 million and $110 million, ...

The US Secret Service has quietly seized nearly $400 million in digital assets over the past decade. Much of the crypto is held in a single cold wallet, now considered one of the largest in the world.

Johns Lyng Group (ASX:JLG) has entered into a scheme implementation deed with Sherwood BidCo, a company controlled by funds managed by Pacific Equity Partners, marking a step towards a proposed ...

Shares of U.S. rare earths miner MP Materials (NYSE:MP) soared by 12.3% to $54.50 in premarket trading today, following a Fox Business report that Apple (NASDAQ:AAPL) is expected to announce a $500 ...

BTCS Inc., a publicly traded blockchain technology company, has purchased an additional 14,522 ETH (CRYPTO:ETH), valued at over $44 million, reflecting increased institutional interest in Ethereum.

Matador Technologies, a Toronto-based Bitcoin (CRYPTO:BTC) company, has announced plans to significantly increase its Bitcoin holdings, aiming to own 1,000 BTC by the end of 2026. The company ...

Cosmo Metals (ASX:CMO) has completed the transfer of the Bingara and Nundle gold, antimony, and copper project tenements to its wholly owned subsidiary. The NSW Resources Department has approved the ...

29Metals (ASX:29M) has received final approvals and commenced surface works at its Gossan Valley Project. The update comes as the company posted improved copper production and stronger liquidity in ...

Citigroup is evaluating the creation of a proprietary stablecoin for cross-border payments, according to an earnings call by CEO Jane Fraser this week.

Clarity Pharmaceuticals (ASX:CU6) has completed patient recruitment for its Co-PSMA trial, a Phase 2 investigator-initiated study evaluating its next-generation diagnostic agent 64Cu-SAR-bisPSMA. Led ...